Literature DB >> 3749007

Relationship between baseline risk factors and coronary heart disease and total mortality in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.

.   

Abstract

The relationship between selected baseline risk factors and subsequent coronary heart disease (CHD) death and total mortality among participants in the Multiple Risk Factor Intervention Trial (MRFIT) was studied in order to determine whether the three risk factors used to identify high-risk men for the trial were associated with CHD death; whether other risk factors measured at baseline, especially lipoprotein cholesterol levels, were associated with CHD and total mortality; and whether there were any differences between special intervention (SI) and usual care (UC) participants in the relationship of the specific levels of risk factors to CHD or total mortality. The three main risk factors (blood cholesterol, cigarette smoking, and diastolic blood pressure) and age were significantly associated with CHD mortality; age, diastolic blood pressure, and cigarette smoking were associated with total mortality. The risk score based on the multiple logistic equation developed from the Framingham Study was also strongly associated with CHD mortality. When the joint associations of selected baseline risk factors with CHD and total mortality were considered, age, diastolic blood pressure, cigarette smoking, and low- and high-density lipoprotein cholesterol were significantly associated with CHD mortality; age, cigarette smoking, and low-density lipoprotein cholesterol were positively associated with total mortality. Systolic blood pressure significantly improved the prediction of CHD mortality for SI and UC men when it was added to a regression model that included age, diastolic blood pressure, cigarettes smoked per day, body mass index, and lipoprotein levels, but improved the prediction of total mortality only for SI men. In similar analyses, serum thiocyanate improved the prediction of both CHD and total mortality for UC men. Among SI men the improved prediction gained by considering serum thiocyanate was less pronounced and not significant for CHD death. This latter finding may be due in part to the changes made in smoking behavior by SI participants during the course of the study. The estimated regression coefficients for CHD and total mortality endpoints were not significantly different between the SI and UC groups.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3749007     DOI: 10.1016/0091-7435(86)90045-9

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  20 in total

1.  Ernst Wynder: a remembrance.

Authors:  Steven D Stellman
Journal:  Prev Med       Date:  2006-09-25       Impact factor: 4.018

2.  Ischemic heart disease and ambient air pollution of particulate matter 2.5 in 51 counties in the U.S.

Authors:  Lina Balluz; Xiao-Jun Wen; Machell Town; Jeffrey D Shire; Judy Qualter; Ali Mokdad
Journal:  Public Health Rep       Date:  2007 Sep-Oct       Impact factor: 2.792

3.  High-density lipoprotein and mortality before age 90 in male physicians.

Authors:  Catherine Rahilly-Tierney; Howard D Sesso; J Michael Gaziano; Luc Djoussé
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-04-03

4.  Lifestyle risk factors predict disability and death in healthy aging adults.

Authors:  Eliza F Chakravarty; Helen B Hubert; Eswar Krishnan; Bonnie B Bruce; Vijaya B Lingala; James F Fries
Journal:  Am J Med       Date:  2012-02       Impact factor: 4.965

5.  Early-life sodium exposure unmasks susceptibility to stroke in hyperlipidemic, hypertensive heterozygous Tg25 rats transgenic for human cholesteryl ester transfer protein.

Authors:  Julius L Decano; Jason C Viereck; Ann C McKee; James A Hamilton; Nelson Ruiz-Opazo; Victoria L M Herrera
Journal:  Circulation       Date:  2009-03-09       Impact factor: 29.690

Review 6.  The importance of aggressive lipid management in patients at risk: evidence from recent clinical trials.

Authors:  Keith C Ferdinand
Journal:  Clin Cardiol       Date:  2004-06       Impact factor: 2.882

7.  Lifestyle interventions reduce coronary heart disease risk: results from the PREMIER Trial.

Authors:  Nisa M Maruthur; Nae-Yuh Wang; Lawrence J Appel
Journal:  Circulation       Date:  2009-04-06       Impact factor: 29.690

8.  Effect of a synthetic prostaglandin E2 analogue, RS-86505-007, on plasma lipids and lipoproteins in patients with moderate hypercholesterolaemia: efficacy and tolerance of treatment and response in different apolipoprotein polymorphism groups.

Authors:  T Korhonen; M J Savolainen; T Jääskeläinen; Y A Kesäniemi
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

9.  Change in high-density lipoprotein cholesterol and incident coronary heart disease in apparently healthy male physicians.

Authors:  Catherine Rahilly-Tierney; Thomas S Bowman; Luc Djoussé; Howard D Sesso; J Michael Gaziano
Journal:  Am J Cardiol       Date:  2008-12-15       Impact factor: 2.778

10.  Implementation of guidelines for the management of arterial hypertension. The impulsion study.

Authors:  Asterios Karagiannis; Apostolos I Hatzitolios; Vasilios G Athyros; Kalliopi Deligianni; Charalambos Charalambous; Christos Papathanakis; Georgios Theodosiou; Theodoros Drakidis; Veronika Chatzikaloudi; Chysanthi Kamilali; Sotirios Matsiras; Athanasios Matziris; Christos Savopoulos; Maria Baltatzi; Jobst Rudolf; Konstantinos Tziomalos; Dimitri P Mikhailidis
Journal:  Open Cardiovasc Med J       Date:  2009-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.